机构：[1]Capital Med Univ, Dept Neurol, Xuanwu Hosp, Beijing 100053, Peoples R China首都医科大学宣武医院[2]Capital Med Univ, China Amer Inst Neurosci, Xuanwu Hosp, Beijing 100053, Peoples R China首都医科大学宣武医院
1. Introduction Stroke remains the second leading cause of death and the third leading cause of death and disability combined worldwide, as indicated by disability-adjusted life-years (DALYs) lost [1]. The highest burden of stroke disability is observed in developing countries of Asia and the stroke belt of the United States [2]. Despite remarkable progress and advancements in evidence-based acute care therapies, such as intravenous thrombolysis and endovascular therapy, the burden of stroke remains significantly high [3].
基金：
National Natural Science Foun-dation of China [82027802, 82371470, 82071468]
第一作者机构：[1]Capital Med Univ, Dept Neurol, Xuanwu Hosp, Beijing 100053, Peoples R China
推荐引用方式(GB/T 7714)：
Wu Chuanjie,Chu Xuehong,Zhu Zhanwei,et al.Improving Long-Term Functional Outcomes of Ischemic Stroke in the Reperfusion Era[J].ENGINEERING.2024,40:15-18.doi:10.1016/j.eng.2024.04.004.
APA：
Wu, Chuanjie,Chu, Xuehong,Zhu, Zhanwei,Wu, Di&Ji, Xunming.(2024).Improving Long-Term Functional Outcomes of Ischemic Stroke in the Reperfusion Era.ENGINEERING,40,
MLA：
Wu, Chuanjie,et al."Improving Long-Term Functional Outcomes of Ischemic Stroke in the Reperfusion Era".ENGINEERING 40.(2024):15-18
